259 related articles for article (PubMed ID: 32736337)
21. Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy.
Stengel H; Vural A; Brunder AM; Heinius A; Appeltshauser L; Fiebig B; Giese F; Dresel C; Papagianni A; Birklein F; Weis J; Huchtemann T; Schmidt C; Körtvelyessy P; Villmann C; Meinl E; Sommer C; Leypoldt F; Doppler K
Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):. PubMed ID: 31454780
[TBL] [Abstract][Full Text] [Related]
22. Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection.
Schwerer B; Neisser A; Bernheimer H
Infect Immun; 1999 May; 67(5):2414-20. PubMed ID: 10225903
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune nodopathies, an emerging diagnostic category.
Martín-Aguilar L; Lleixà C; Pascual-Goñi E
Curr Opin Neurol; 2022 Oct; 35(5):579-585. PubMed ID: 35989582
[TBL] [Abstract][Full Text] [Related]
24. Changes of Serum IgG Dimer Levels after Treatment with IVIg in Guillain-Barré Syndrome.
Svačina MKR; Röth P; Bobylev I; Sprenger A; Zhang G; Sheikh KA; Lehmann HC
J Neuroimmune Pharmacol; 2019 Dec; 14(4):642-648. PubMed ID: 31515689
[TBL] [Abstract][Full Text] [Related]
25. IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.
Fokkink WJ; Selman MH; Dortland JR; Durmuş B; Kuitwaard K; Huizinga R; van Rijs W; Tio-Gillen AP; van Doorn PA; Deelder AM; Wuhrer M; Jacobs BC
J Proteome Res; 2014 Mar; 13(3):1722-30. PubMed ID: 24533874
[TBL] [Abstract][Full Text] [Related]
26. CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies.
Nishino S; Kanbayashi T; Fujiki N; Uchino M; Ripley B; Watanabe M; Lammers GJ; Ishiguro H; Shoji S; Nishida Y; Overeem S; Toyoshima I; Yoshida Y; Shimizu T; Taheri S; Mignot E
Neurology; 2003 Sep; 61(6):823-5. PubMed ID: 14504329
[TBL] [Abstract][Full Text] [Related]
27. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
[TBL] [Abstract][Full Text] [Related]
28. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
29. Oligoclonal IgG bands in chronic inflammatory polyradiculoneuropathies.
Ruiz M; Puthenparampil M; Campagnolo M; Castellani F; Salvalaggio A; Ruggero S; Toffanin E; Cacciavillani M; Gallo P; Franciotta D; Briani C
J Neurol Neurosurg Psychiatry; 2021 Sep; 92(9):969-974. PubMed ID: 33850000
[TBL] [Abstract][Full Text] [Related]
30. Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins.
Kouton L; Boucraut J; Devaux J; Rajabally YA; Adams D; Antoine JC; Bourdain F; Brodovitch A; Camdessanché JP; Cauquil C; Ciron J; Dubard T; Echaniz-Laguna A; Grapperon AM; Juntas-Morales R; Kremer L; Kuntzer T; Labeyrie C; Lanfranco L; Léger JM; Maisonobe T; Mavroudakis N; Mecharles-Darrigol S; Merle P; Noury JB; Rouaud V; Tard C; Théaudin M; Vallat JM; Viala K; Attarian S; Delmont E
Clin Neurophysiol; 2020 Apr; 131(4):921-927. PubMed ID: 32078921
[TBL] [Abstract][Full Text] [Related]
31. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.
Querol L; Nogales-Gadea G; Rojas-Garcia R; Martinez-Hernandez E; Diaz-Manera J; Suárez-Calvet X; Navas M; Araque J; Gallardo E; Illa I
Ann Neurol; 2013 Mar; 73(3):370-80. PubMed ID: 23280477
[TBL] [Abstract][Full Text] [Related]
33. Paranodal destruction and axo-glial dysjunction in a subtype of CIDP with anticontaction-1 antibodies.
Kuwabara S; Misawa S; Mori M
J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):707. PubMed ID: 25758172
[No Abstract] [Full Text] [Related]
34. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
[TBL] [Abstract][Full Text] [Related]
35. Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China.
Zhang X; Zheng P; Devaux JJ; Wang Y; Liu C; Li J; Guo S; Song Y; Wang Q; Feng X; Wang Y
J Neuroimmunol; 2019 Dec; 337():577074. PubMed ID: 31693967
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier.
Devaux JJ
Am J Pathol; 2012 Oct; 181(4):1402-13. PubMed ID: 22885108
[TBL] [Abstract][Full Text] [Related]
37. Chronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulins.
Ritter C; Bobylev I; Lehmann HC
J Neuroinflammation; 2015 Aug; 12():148. PubMed ID: 26268846
[TBL] [Abstract][Full Text] [Related]
38. Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies.
Heming M; Schulte-Mecklenbeck A; Brix T; Wolbert J; Ruland T; Klotz L; Meuth SG; Gross CC; Wiendl H; Meyer Zu Hörste G
Front Immunol; 2019; 10():515. PubMed ID: 30984164
[No Abstract] [Full Text] [Related]
39. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
Radziwill AJ; Kuntzer T; Steck AJ
Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
[TBL] [Abstract][Full Text] [Related]
40. Serological study using glycoarray for detecting antibodies to glycolipids and glycolipid complexes in immune-mediated neuropathies.
Morikawa M; Kuwahara M; Ueno R; Samukawa M; Hamada Y; Kusunoki S
J Neuroimmunol; 2016 Dec; 301():35-40. PubMed ID: 27836184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
